Login to Your Account

JPMorgan H&Q Healthcare Conference

Medarex, Genmab, OGS Launch Bid For Breast Cancer Therapies

By Randall Osborne

Thursday, January 10, 2002
While attendees of the annual JPMorgan H&Q Healthcare Conference scurried through the hallways of the Westin St. Francis hotel here, transgenic mouse company Medarex Inc. let loose a box full of news, including a three-way deal against breast cancer that is the fulfillment of the original promise of genomics and proteomics to turn target discovery into product development, said Donald Drakeman, president and CEO.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription